Avantis Medical Systems, Inc., the Sunnyvale, Calif. based creator of the Third Eye Retroscope–a device that adds an extra view to a colonoscope, has raised $3,048,468 of venture capital to further commercialize its flagship product in the U.S., make small improvements to the product, as well as using a “little bit” work toward earning a CE Mark in Europe, President and CEO Tony DiTonno said.
The company, in Series D funding, seeks about $4.95 million more, according to the regulatory filing it made with the SEC.
DiTonno said he expects the company to be acquired in 18 months to two years.
The officers and directors listed on the filing include DiTonno, who previously served as CEO for NeurogesX and LifeSleep; Director Dr. Thomas Fogarty; former Director Matthew Jenusaitis; Director Dr. Camran Nezhat, a general partner at CN Investment; Director Howard Palefsky, managing director at Montreux Equity Partners; and Director Dr. John Savarese, also a managing director at Montreux Equity.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
